Unichem Pharmaceuticals voluntarily recalled one lot of its hydrochlorothiazide tablets after a clopidogrel tablet was found in a bottle. The affected lot (GHYL15028) was distributed to wholesalers, retailers and pharmacies from May 21 to 28, according to an FDA news release.
Patients are prescribed hydrochlorothiazide to manage high blood pressure and edema. Clopidogrel is a blood thinner used to prevent heart attacks and strokes.
If patients take clopidogrel instead of hydrochlorothiazide, they may experience side effects such as bleeding and/or bruising, according to the FDA. They may also experience edema if they miss a dose of hydrochlorothiazide.
Unichem said the recall did not effect any other lots of hydrochlorothiazide, and it had not received any reports of adverse events.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.